Also found in: Medical.
NOMIDNeonatal Onset Multisystem Inflammatory Disease
References in periodicals archive ?
is a recombinant protein drug approved for the treatment of children and adults with NOMID, and the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis (RA), in patients 18 years of age or older who have failed one or more disease modifying antirheumatic drugs (DMARDs).
The filing of Kineret for CAPS and NOMID in the EU and the US respectively are important milestones on Sobi's journey to increase our support for the pediatric rheumatology field as well as for the rare disease community as a whole," said Dr.
IL-1 is overproduced in NOMID and a number of other diseases, leading to damaging inflammation.